nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS1—esophageal cancer	0.512	0.636	CbGaD
Desmopressin—PTGS2—esophageal cancer	0.293	0.364	CbGaD
Desmopressin—PTGS2—Cisplatin—esophageal cancer	0.0141	1	CbGbCtD
Desmopressin—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.0015	0.0217	CcSEcCtD
Desmopressin—Depressed mood—Capecitabine—esophageal cancer	0.00144	0.0208	CcSEcCtD
Desmopressin—Altered state of consciousness—Capecitabine—esophageal cancer	0.00139	0.0201	CcSEcCtD
Desmopressin—Infection—Carboplatin—esophageal cancer	0.00105	0.0152	CcSEcCtD
Desmopressin—Thrombosis—Capecitabine—esophageal cancer	0.000908	0.0131	CcSEcCtD
Desmopressin—Pain—Carboplatin—esophageal cancer	0.000907	0.0131	CcSEcCtD
Desmopressin—Throat sore—Capecitabine—esophageal cancer	0.000892	0.0129	CcSEcCtD
Desmopressin—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000884	0.0128	CcSEcCtD
Desmopressin—Wheezing—Cisplatin—esophageal cancer	0.000847	0.0122	CcSEcCtD
Desmopressin—Body temperature increased—Carboplatin—esophageal cancer	0.000838	0.0121	CcSEcCtD
Desmopressin—Fluid retention—Cisplatin—esophageal cancer	0.000828	0.012	CcSEcCtD
Desmopressin—Memory impairment—Capecitabine—esophageal cancer	0.000819	0.0118	CcSEcCtD
Desmopressin—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000707	0.0102	CcSEcCtD
Desmopressin—Nasal congestion—Cisplatin—esophageal cancer	0.000695	0.01	CcSEcCtD
Desmopressin—Hyponatraemia—Cisplatin—esophageal cancer	0.000635	0.00918	CcSEcCtD
Desmopressin—Influenza like illness—Capecitabine—esophageal cancer	0.000624	0.00902	CcSEcCtD
Desmopressin—Depressed level of consciousness—Capecitabine—esophageal cancer	0.000621	0.00896	CcSEcCtD
Desmopressin—Fluid retention—Capecitabine—esophageal cancer	0.00061	0.00881	CcSEcCtD
Desmopressin—Irritability—Cisplatin—esophageal cancer	0.000604	0.00873	CcSEcCtD
Desmopressin—Dehydration—Cisplatin—esophageal cancer	0.000589	0.0085	CcSEcCtD
Desmopressin—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000578	0.00835	CcSEcCtD
Desmopressin—Hypokalaemia—Cisplatin—esophageal cancer	0.000576	0.00832	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00057	0.00823	CcSEcCtD
Desmopressin—Cramp muscle—Cisplatin—esophageal cancer	0.00057	0.00823	CcSEcCtD
Desmopressin—Mental disability—Capecitabine—esophageal cancer	0.000558	0.00806	CcSEcCtD
Desmopressin—Swelling—Capecitabine—esophageal cancer	0.000529	0.00764	CcSEcCtD
Desmopressin—Gastroenteritis—Capecitabine—esophageal cancer	0.000526	0.0076	CcSEcCtD
Desmopressin—Oliguria—Methotrexate—esophageal cancer	0.000519	0.0075	CcSEcCtD
Desmopressin—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000506	0.00731	CcSEcCtD
Desmopressin—Increased appetite—Capecitabine—esophageal cancer	0.000497	0.00717	CcSEcCtD
Desmopressin—Conjunctivitis—Cisplatin—esophageal cancer	0.000474	0.00685	CcSEcCtD
Desmopressin—Hyponatraemia—Capecitabine—esophageal cancer	0.000468	0.00677	CcSEcCtD
Desmopressin—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000462	0.00667	CcSEcCtD
Desmopressin—Irritability—Capecitabine—esophageal cancer	0.000445	0.00643	CcSEcCtD
Desmopressin—Mood swings—Capecitabine—esophageal cancer	0.000442	0.00638	CcSEcCtD
Desmopressin—Coma—Methotrexate—esophageal cancer	0.000437	0.00632	CcSEcCtD
Desmopressin—Dehydration—Capecitabine—esophageal cancer	0.000434	0.00627	CcSEcCtD
Desmopressin—Urinary tract disorder—Cisplatin—esophageal cancer	0.000432	0.00625	CcSEcCtD
Desmopressin—Connective tissue disorder—Cisplatin—esophageal cancer	0.00043	0.00622	CcSEcCtD
Desmopressin—Urethral disorder—Cisplatin—esophageal cancer	0.000429	0.0062	CcSEcCtD
Desmopressin—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000426	0.00616	CcSEcCtD
Desmopressin—Hypokalaemia—Capecitabine—esophageal cancer	0.000425	0.00613	CcSEcCtD
Desmopressin—Visual impairment—Cisplatin—esophageal cancer	0.000422	0.0061	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00042	0.00607	CcSEcCtD
Desmopressin—Eye disorder—Cisplatin—esophageal cancer	0.000409	0.00591	CcSEcCtD
Desmopressin—Cardiac disorder—Cisplatin—esophageal cancer	0.000406	0.00587	CcSEcCtD
Desmopressin—Flushing—Cisplatin—esophageal cancer	0.000406	0.00587	CcSEcCtD
Desmopressin—Abdominal distension—Capecitabine—esophageal cancer	0.000406	0.00586	CcSEcCtD
Desmopressin—Influenza—Capecitabine—esophageal cancer	0.000403	0.00582	CcSEcCtD
Desmopressin—Immune system disorder—Cisplatin—esophageal cancer	0.000396	0.00571	CcSEcCtD
Desmopressin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000395	0.0057	CcSEcCtD
Desmopressin—Erythema—Cisplatin—esophageal cancer	0.000381	0.00551	CcSEcCtD
Desmopressin—Malnutrition—Cisplatin—esophageal cancer	0.000381	0.00551	CcSEcCtD
Desmopressin—Flatulence—Cisplatin—esophageal cancer	0.000376	0.00543	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000375	0.00541	CcSEcCtD
Desmopressin—Weight increased—Capecitabine—esophageal cancer	0.000367	0.0053	CcSEcCtD
Desmopressin—Muscle spasms—Cisplatin—esophageal cancer	0.000366	0.00529	CcSEcCtD
Desmopressin—Depression—Capecitabine—esophageal cancer	0.000359	0.00518	CcSEcCtD
Desmopressin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000354	0.00511	CcSEcCtD
Desmopressin—Conjunctivitis—Capecitabine—esophageal cancer	0.000349	0.00505	CcSEcCtD
Desmopressin—Malaise—Cisplatin—esophageal cancer	0.000344	0.00497	CcSEcCtD
Desmopressin—Epistaxis—Capecitabine—esophageal cancer	0.000339	0.0049	CcSEcCtD
Desmopressin—Irritability—Methotrexate—esophageal cancer	0.000332	0.00479	CcSEcCtD
Desmopressin—Convulsion—Cisplatin—esophageal cancer	0.00033	0.00477	CcSEcCtD
Desmopressin—Mood swings—Methotrexate—esophageal cancer	0.000329	0.00475	CcSEcCtD
Desmopressin—Myalgia—Cisplatin—esophageal cancer	0.000325	0.00469	CcSEcCtD
Desmopressin—Rhinitis—Capecitabine—esophageal cancer	0.000324	0.00467	CcSEcCtD
Desmopressin—Anxiety—Cisplatin—esophageal cancer	0.000323	0.00467	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000322	0.00466	CcSEcCtD
Desmopressin—Discomfort—Cisplatin—esophageal cancer	0.000321	0.00463	CcSEcCtD
Desmopressin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000319	0.0046	CcSEcCtD
Desmopressin—Oedema peripheral—Capecitabine—esophageal cancer	0.000318	0.00459	CcSEcCtD
Desmopressin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000317	0.00458	CcSEcCtD
Desmopressin—Urethral disorder—Capecitabine—esophageal cancer	0.000316	0.00457	CcSEcCtD
Desmopressin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000311	0.00449	CcSEcCtD
Desmopressin—Oedema—Cisplatin—esophageal cancer	0.000311	0.00449	CcSEcCtD
Desmopressin—Visual impairment—Capecitabine—esophageal cancer	0.000311	0.00449	CcSEcCtD
Desmopressin—Infection—Cisplatin—esophageal cancer	0.000309	0.00446	CcSEcCtD
Desmopressin—Nervous system disorder—Cisplatin—esophageal cancer	0.000305	0.00441	CcSEcCtD
Desmopressin—Tachycardia—Cisplatin—esophageal cancer	0.000304	0.00439	CcSEcCtD
Desmopressin—Skin disorder—Cisplatin—esophageal cancer	0.000302	0.00436	CcSEcCtD
Desmopressin—Eye disorder—Capecitabine—esophageal cancer	0.000302	0.00436	CcSEcCtD
Desmopressin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000301	0.00434	CcSEcCtD
Desmopressin—Flushing—Capecitabine—esophageal cancer	0.0003	0.00433	CcSEcCtD
Desmopressin—Cardiac disorder—Capecitabine—esophageal cancer	0.0003	0.00433	CcSEcCtD
Desmopressin—Anorexia—Cisplatin—esophageal cancer	0.000297	0.00428	CcSEcCtD
Desmopressin—Angiopathy—Capecitabine—esophageal cancer	0.000293	0.00423	CcSEcCtD
Desmopressin—Immune system disorder—Capecitabine—esophageal cancer	0.000292	0.00421	CcSEcCtD
Desmopressin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000291	0.0042	CcSEcCtD
Desmopressin—Chills—Capecitabine—esophageal cancer	0.00029	0.00418	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000283	0.00409	CcSEcCtD
Desmopressin—Mental disorder—Capecitabine—esophageal cancer	0.000283	0.00408	CcSEcCtD
Desmopressin—Erythema—Capecitabine—esophageal cancer	0.000281	0.00406	CcSEcCtD
Desmopressin—Malnutrition—Capecitabine—esophageal cancer	0.000281	0.00406	CcSEcCtD
Desmopressin—Paraesthesia—Cisplatin—esophageal cancer	0.000279	0.00403	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000279	0.00403	CcSEcCtD
Desmopressin—Dyspnoea—Cisplatin—esophageal cancer	0.000277	0.00401	CcSEcCtD
Desmopressin—Flatulence—Capecitabine—esophageal cancer	0.000277	0.004	CcSEcCtD
Desmopressin—Decreased appetite—Cisplatin—esophageal cancer	0.00027	0.00391	CcSEcCtD
Desmopressin—Muscle spasms—Capecitabine—esophageal cancer	0.00027	0.0039	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000269	0.00388	CcSEcCtD
Desmopressin—Depression—Methotrexate—esophageal cancer	0.000267	0.00386	CcSEcCtD
Desmopressin—Pain—Cisplatin—esophageal cancer	0.000266	0.00384	CcSEcCtD
Desmopressin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000261	0.00377	CcSEcCtD
Desmopressin—Conjunctivitis—Methotrexate—esophageal cancer	0.00026	0.00376	CcSEcCtD
Desmopressin—Sweating—Methotrexate—esophageal cancer	0.000257	0.00371	CcSEcCtD
Desmopressin—Feeling abnormal—Cisplatin—esophageal cancer	0.000256	0.0037	CcSEcCtD
Desmopressin—Malaise—Capecitabine—esophageal cancer	0.000253	0.00366	CcSEcCtD
Desmopressin—Epistaxis—Methotrexate—esophageal cancer	0.000252	0.00365	CcSEcCtD
Desmopressin—Vertigo—Capecitabine—esophageal cancer	0.000252	0.00365	CcSEcCtD
Desmopressin—Syncope—Capecitabine—esophageal cancer	0.000252	0.00364	CcSEcCtD
Desmopressin—Palpitations—Capecitabine—esophageal cancer	0.000248	0.00359	CcSEcCtD
Desmopressin—Loss of consciousness—Capecitabine—esophageal cancer	0.000247	0.00357	CcSEcCtD
Desmopressin—Body temperature increased—Cisplatin—esophageal cancer	0.000246	0.00355	CcSEcCtD
Desmopressin—Cough—Capecitabine—esophageal cancer	0.000245	0.00354	CcSEcCtD
Desmopressin—Hypertension—Capecitabine—esophageal cancer	0.000243	0.0035	CcSEcCtD
Desmopressin—Myalgia—Capecitabine—esophageal cancer	0.000239	0.00346	CcSEcCtD
Desmopressin—Chest pain—Capecitabine—esophageal cancer	0.000239	0.00346	CcSEcCtD
Desmopressin—Anxiety—Capecitabine—esophageal cancer	0.000238	0.00344	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000238	0.00343	CcSEcCtD
Desmopressin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000237	0.00343	CcSEcCtD
Desmopressin—Discomfort—Capecitabine—esophageal cancer	0.000236	0.00341	CcSEcCtD
Desmopressin—Urethral disorder—Methotrexate—esophageal cancer	0.000236	0.0034	CcSEcCtD
Desmopressin—Visual impairment—Methotrexate—esophageal cancer	0.000232	0.00334	CcSEcCtD
Desmopressin—Confusional state—Capecitabine—esophageal cancer	0.000231	0.00334	CcSEcCtD
Desmopressin—Oedema—Capecitabine—esophageal cancer	0.000229	0.00331	CcSEcCtD
Desmopressin—Hypersensitivity—Cisplatin—esophageal cancer	0.000229	0.00331	CcSEcCtD
Desmopressin—Infection—Capecitabine—esophageal cancer	0.000228	0.00329	CcSEcCtD
Desmopressin—Shock—Capecitabine—esophageal cancer	0.000226	0.00326	CcSEcCtD
Desmopressin—Nervous system disorder—Capecitabine—esophageal cancer	0.000225	0.00325	CcSEcCtD
Desmopressin—Eye disorder—Methotrexate—esophageal cancer	0.000225	0.00324	CcSEcCtD
Desmopressin—Tachycardia—Capecitabine—esophageal cancer	0.000224	0.00323	CcSEcCtD
Desmopressin—Asthenia—Cisplatin—esophageal cancer	0.000223	0.00322	CcSEcCtD
Desmopressin—Cardiac disorder—Methotrexate—esophageal cancer	0.000223	0.00322	CcSEcCtD
Desmopressin—Skin disorder—Capecitabine—esophageal cancer	0.000223	0.00322	CcSEcCtD
Desmopressin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000222	0.0032	CcSEcCtD
Desmopressin—Anorexia—Capecitabine—esophageal cancer	0.000219	0.00316	CcSEcCtD
Desmopressin—Angiopathy—Methotrexate—esophageal cancer	0.000218	0.00315	CcSEcCtD
Desmopressin—Immune system disorder—Methotrexate—esophageal cancer	0.000217	0.00313	CcSEcCtD
Desmopressin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000217	0.00313	CcSEcCtD
Desmopressin—Chills—Methotrexate—esophageal cancer	0.000216	0.00311	CcSEcCtD
Desmopressin—Diarrhoea—Cisplatin—esophageal cancer	0.000213	0.00307	CcSEcCtD
Desmopressin—Mental disorder—Methotrexate—esophageal cancer	0.000211	0.00304	CcSEcCtD
Desmopressin—Erythema—Methotrexate—esophageal cancer	0.000209	0.00302	CcSEcCtD
Desmopressin—Malnutrition—Methotrexate—esophageal cancer	0.000209	0.00302	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000209	0.00302	CcSEcCtD
Desmopressin—Insomnia—Capecitabine—esophageal cancer	0.000207	0.003	CcSEcCtD
Desmopressin—Paraesthesia—Capecitabine—esophageal cancer	0.000206	0.00297	CcSEcCtD
Desmopressin—Dyspnoea—Capecitabine—esophageal cancer	0.000204	0.00295	CcSEcCtD
Desmopressin—Dyspepsia—Capecitabine—esophageal cancer	0.000202	0.00292	CcSEcCtD
Desmopressin—Decreased appetite—Capecitabine—esophageal cancer	0.000199	0.00288	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000198	0.00286	CcSEcCtD
Desmopressin—Vomiting—Cisplatin—esophageal cancer	0.000198	0.00286	CcSEcCtD
Desmopressin—Fatigue—Capecitabine—esophageal cancer	0.000198	0.00286	CcSEcCtD
Desmopressin—Rash—Cisplatin—esophageal cancer	0.000196	0.00283	CcSEcCtD
Desmopressin—Pain—Capecitabine—esophageal cancer	0.000196	0.00283	CcSEcCtD
Desmopressin—Constipation—Capecitabine—esophageal cancer	0.000196	0.00283	CcSEcCtD
Desmopressin—Dermatitis—Cisplatin—esophageal cancer	0.000196	0.00283	CcSEcCtD
Desmopressin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000194	0.0028	CcSEcCtD
Desmopressin—Feeling abnormal—Capecitabine—esophageal cancer	0.000189	0.00273	CcSEcCtD
Desmopressin—Malaise—Methotrexate—esophageal cancer	0.000189	0.00272	CcSEcCtD
Desmopressin—Vertigo—Methotrexate—esophageal cancer	0.000188	0.00271	CcSEcCtD
Desmopressin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000188	0.00271	CcSEcCtD
Desmopressin—Nausea—Cisplatin—esophageal cancer	0.000185	0.00267	CcSEcCtD
Desmopressin—Cough—Methotrexate—esophageal cancer	0.000183	0.00264	CcSEcCtD
Desmopressin—Urticaria—Capecitabine—esophageal cancer	0.000182	0.00263	CcSEcCtD
Desmopressin—Abdominal pain—Capecitabine—esophageal cancer	0.000181	0.00262	CcSEcCtD
Desmopressin—Body temperature increased—Capecitabine—esophageal cancer	0.000181	0.00262	CcSEcCtD
Desmopressin—Convulsion—Methotrexate—esophageal cancer	0.000181	0.00262	CcSEcCtD
Desmopressin—Myalgia—Methotrexate—esophageal cancer	0.000178	0.00257	CcSEcCtD
Desmopressin—Chest pain—Methotrexate—esophageal cancer	0.000178	0.00257	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000177	0.00255	CcSEcCtD
Desmopressin—Discomfort—Methotrexate—esophageal cancer	0.000176	0.00254	CcSEcCtD
Desmopressin—Confusional state—Methotrexate—esophageal cancer	0.000172	0.00249	CcSEcCtD
Desmopressin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000171	0.00247	CcSEcCtD
Desmopressin—Infection—Methotrexate—esophageal cancer	0.00017	0.00245	CcSEcCtD
Desmopressin—Hypersensitivity—Capecitabine—esophageal cancer	0.000169	0.00244	CcSEcCtD
Desmopressin—Nervous system disorder—Methotrexate—esophageal cancer	0.000167	0.00242	CcSEcCtD
Desmopressin—Skin disorder—Methotrexate—esophageal cancer	0.000166	0.0024	CcSEcCtD
Desmopressin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000165	0.00238	CcSEcCtD
Desmopressin—Asthenia—Capecitabine—esophageal cancer	0.000165	0.00238	CcSEcCtD
Desmopressin—Anorexia—Methotrexate—esophageal cancer	0.000163	0.00235	CcSEcCtD
Desmopressin—Pruritus—Capecitabine—esophageal cancer	0.000162	0.00234	CcSEcCtD
Desmopressin—Diarrhoea—Capecitabine—esophageal cancer	0.000157	0.00227	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000156	0.00225	CcSEcCtD
Desmopressin—Insomnia—Methotrexate—esophageal cancer	0.000154	0.00223	CcSEcCtD
Desmopressin—Paraesthesia—Methotrexate—esophageal cancer	0.000153	0.00221	CcSEcCtD
Desmopressin—Dyspnoea—Methotrexate—esophageal cancer	0.000152	0.0022	CcSEcCtD
Desmopressin—Somnolence—Methotrexate—esophageal cancer	0.000152	0.00219	CcSEcCtD
Desmopressin—Dizziness—Capecitabine—esophageal cancer	0.000152	0.00219	CcSEcCtD
Desmopressin—Dyspepsia—Methotrexate—esophageal cancer	0.00015	0.00217	CcSEcCtD
Desmopressin—Decreased appetite—Methotrexate—esophageal cancer	0.000148	0.00214	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000147	0.00213	CcSEcCtD
Desmopressin—Fatigue—Methotrexate—esophageal cancer	0.000147	0.00213	CcSEcCtD
Desmopressin—Pain—Methotrexate—esophageal cancer	0.000146	0.00211	CcSEcCtD
Desmopressin—Vomiting—Capecitabine—esophageal cancer	0.000146	0.00211	CcSEcCtD
Desmopressin—Rash—Capecitabine—esophageal cancer	0.000145	0.00209	CcSEcCtD
Desmopressin—Dermatitis—Capecitabine—esophageal cancer	0.000144	0.00209	CcSEcCtD
Desmopressin—Headache—Capecitabine—esophageal cancer	0.000144	0.00208	CcSEcCtD
Desmopressin—Feeling abnormal—Methotrexate—esophageal cancer	0.000141	0.00203	CcSEcCtD
Desmopressin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00014	0.00202	CcSEcCtD
Desmopressin—Nausea—Capecitabine—esophageal cancer	0.000136	0.00197	CcSEcCtD
Desmopressin—Urticaria—Methotrexate—esophageal cancer	0.000136	0.00196	CcSEcCtD
Desmopressin—Body temperature increased—Methotrexate—esophageal cancer	0.000135	0.00195	CcSEcCtD
Desmopressin—Abdominal pain—Methotrexate—esophageal cancer	0.000135	0.00195	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—PFN1—esophageal cancer	0.000128	0.00115	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—GHRL—esophageal cancer	0.000128	0.00115	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PFN1—esophageal cancer	0.000127	0.00114	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CREBBP—esophageal cancer	0.000127	0.00114	CbGpPWpGaD
Desmopressin—AVPR1A—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000126	0.00113	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000126	0.00113	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000126	0.00113	CbGpPWpGaD
Desmopressin—Hypersensitivity—Methotrexate—esophageal cancer	0.000126	0.00182	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—CTNNA1—esophageal cancer	0.000125	0.00112	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000125	0.00112	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CXCL2—esophageal cancer	0.000124	0.00112	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	0.000124	0.00112	CbGpPWpGaD
Desmopressin—Asthenia—Methotrexate—esophageal cancer	0.000122	0.00177	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000122	0.00109	CbGpPWpGaD
Desmopressin—Pruritus—Methotrexate—esophageal cancer	0.000121	0.00174	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00012	0.00107	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000119	0.00107	CbGpPWpGaD
Desmopressin—Diarrhoea—Methotrexate—esophageal cancer	0.000117	0.00169	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—PSME1—esophageal cancer	0.000116	0.00104	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PSME2—esophageal cancer	0.000116	0.00104	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ANXA1—esophageal cancer	0.000116	0.00104	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ELMO1—esophageal cancer	0.000115	0.00103	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ELMO1—esophageal cancer	0.000114	0.00103	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TLR4—esophageal cancer	0.000113	0.00101	CbGpPWpGaD
Desmopressin—Dizziness—Methotrexate—esophageal cancer	0.000113	0.00163	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000113	0.00101	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKAP13—esophageal cancer	0.000112	0.00101	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SST—esophageal cancer	0.000112	0.00101	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKAP13—esophageal cancer	0.000112	0.001	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000111	0.000996	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NOTCH3—esophageal cancer	0.00011	0.000985	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—GHRL—esophageal cancer	0.00011	0.000985	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—BCL2—esophageal cancer	0.000109	0.00098	CbGpPWpGaD
Desmopressin—Vomiting—Methotrexate—esophageal cancer	0.000109	0.00157	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—FBXW7—esophageal cancer	0.000108	0.000969	CbGpPWpGaD
Desmopressin—Rash—Methotrexate—esophageal cancer	0.000108	0.00155	CcSEcCtD
Desmopressin—Dermatitis—Methotrexate—esophageal cancer	0.000108	0.00155	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—NOS2—esophageal cancer	0.000107	0.000965	CbGpPWpGaD
Desmopressin—Headache—Methotrexate—esophageal cancer	0.000107	0.00154	CcSEcCtD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000106	0.000956	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000104	0.000932	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000103	0.000926	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PDE4D—esophageal cancer	0.000103	0.000924	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PDE4D—esophageal cancer	0.000102	0.000917	CbGpPWpGaD
Desmopressin—Nausea—Methotrexate—esophageal cancer	0.000101	0.00146	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000101	0.000911	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NOTCH2—esophageal cancer	9.83e-05	0.000883	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	9.82e-05	0.000882	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	9.82e-05	0.000882	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—GNG7—esophageal cancer	9.79e-05	0.000879	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GNG7—esophageal cancer	9.72e-05	0.000873	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.7e-05	0.000871	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	9.61e-05	0.000863	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	9.37e-05	0.000841	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	9.29e-05	0.000834	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.29e-05	0.000834	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—XIAP—esophageal cancer	9.17e-05	0.000824	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—XIAP—esophageal cancer	9.1e-05	0.000818	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	9.06e-05	0.000814	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TGFBR2—esophageal cancer	8.72e-05	0.000783	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CTNNA1—esophageal cancer	8.67e-05	0.000779	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	8.62e-05	0.000774	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CXCL2—esophageal cancer	8.62e-05	0.000774	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CTNNA1—esophageal cancer	8.61e-05	0.000773	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CXCL2—esophageal cancer	8.56e-05	0.000769	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.45e-05	0.000759	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SMAD4—esophageal cancer	8.26e-05	0.000742	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC52A3—esophageal cancer	8.25e-05	0.000741	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—BLVRB—esophageal cancer	8.25e-05	0.000741	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PSME2—esophageal cancer	8.05e-05	0.000723	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PSME1—esophageal cancer	8.05e-05	0.000723	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ANXA1—esophageal cancer	8.02e-05	0.00072	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PSME1—esophageal cancer	8e-05	0.000718	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PSME2—esophageal cancer	8e-05	0.000718	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ANXA1—esophageal cancer	7.96e-05	0.000715	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SLC52A3—esophageal cancer	7.82e-05	0.000702	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SST—esophageal cancer	7.8e-05	0.0007	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SST—esophageal cancer	7.74e-05	0.000695	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—GHRL—esophageal cancer	7.6e-05	0.000682	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NOTCH3—esophageal cancer	7.6e-05	0.000682	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NOTCH3—esophageal cancer	7.54e-05	0.000678	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GHRL—esophageal cancer	7.54e-05	0.000678	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	7.51e-05	0.000675	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—FBXW7—esophageal cancer	7.48e-05	0.000671	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KMT2D—esophageal cancer	7.46e-05	0.00067	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—FBXW7—esophageal cancer	7.42e-05	0.000667	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.37e-05	0.000662	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	7.14e-05	0.000641	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CA1—esophageal cancer	7.02e-05	0.00063	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC10A2—esophageal cancer	7.02e-05	0.00063	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NOTCH2—esophageal cancer	6.82e-05	0.000612	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NOTCH2—esophageal cancer	6.77e-05	0.000608	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HIF1A—esophageal cancer	6.76e-05	0.000607	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.59e-05	0.000592	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	6.56e-05	0.000589	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC52A3—esophageal cancer	6.55e-05	0.000588	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—BLVRB—esophageal cancer	6.55e-05	0.000588	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KDR—esophageal cancer	6.46e-05	0.00058	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CA2—esophageal cancer	6.42e-05	0.000576	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.27e-05	0.000563	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NOTCH1—esophageal cancer	6.09e-05	0.000547	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TGFBR2—esophageal cancer	6.05e-05	0.000543	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TGFBR2—esophageal cancer	6e-05	0.000539	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PLCE1—esophageal cancer	5.97e-05	0.000536	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ADH7—esophageal cancer	5.97e-05	0.000536	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.9e-05	0.00053	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.86e-05	0.000526	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FKBP1A—esophageal cancer	5.79e-05	0.00052	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	5.73e-05	0.000514	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SMAD4—esophageal cancer	5.72e-05	0.000514	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SMAD4—esophageal cancer	5.68e-05	0.00051	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.66e-05	0.000508	CbGpPWpGaD
Desmopressin—PTGS2—Disease—WIF1—esophageal cancer	5.66e-05	0.000508	CbGpPWpGaD
Desmopressin—PTGS2—Disease—DOCK2—esophageal cancer	5.66e-05	0.000508	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	5.6e-05	0.000503	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CA1—esophageal cancer	5.57e-05	0.0005	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC10A2—esophageal cancer	5.57e-05	0.0005	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CREBBP—esophageal cancer	5.52e-05	0.000496	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.5e-05	0.000494	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—EGFR—esophageal cancer	5.42e-05	0.000487	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ADH1B—esophageal cancer	5.23e-05	0.00047	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CSNK1A1—esophageal cancer	5.22e-05	0.000469	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	5.18e-05	0.000465	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CA2—esophageal cancer	5.09e-05	0.000458	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TYMP—esophageal cancer	5e-05	0.000449	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.98e-05	0.000447	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NOS3—esophageal cancer	4.94e-05	0.000444	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP26A1—esophageal cancer	4.86e-05	0.000437	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.86e-05	0.000436	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ALOX15—esophageal cancer	4.74e-05	0.000426	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ADH7—esophageal cancer	4.74e-05	0.000425	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PLCE1—esophageal cancer	4.74e-05	0.000425	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—PIK3CA—esophageal cancer	4.71e-05	0.000423	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	4.7e-05	0.000422	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.7e-05	0.000422	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HIF1A—esophageal cancer	4.68e-05	0.000421	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.68e-05	0.00042	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HIF1A—esophageal cancer	4.65e-05	0.000418	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ERBB2—esophageal cancer	4.62e-05	0.000415	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TPI1—esophageal cancer	4.52e-05	0.000406	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTO1—esophageal cancer	4.52e-05	0.000406	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KDR—esophageal cancer	4.48e-05	0.000402	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.47e-05	0.000401	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KDR—esophageal cancer	4.45e-05	0.000399	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ELMO1—esophageal cancer	4.39e-05	0.000394	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ALDOB—esophageal cancer	4.33e-05	0.000389	CbGpPWpGaD
Desmopressin—PTGS2—Disease—GSTO1—esophageal cancer	4.29e-05	0.000385	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TPI1—esophageal cancer	4.29e-05	0.000385	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NOTCH1—esophageal cancer	4.22e-05	0.000379	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NOTCH1—esophageal cancer	4.19e-05	0.000376	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GAPDH—esophageal cancer	4.17e-05	0.000375	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ADH1B—esophageal cancer	4.15e-05	0.000373	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CRABP1—esophageal cancer	4.14e-05	0.000371	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ALDOB—esophageal cancer	4.11e-05	0.000369	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CCND1—esophageal cancer	4.08e-05	0.000367	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TYMP—esophageal cancer	3.97e-05	0.000356	CbGpPWpGaD
Desmopressin—PTGS2—Disease—GAPDH—esophageal cancer	3.96e-05	0.000355	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HIST1H2BM—esophageal cancer	3.96e-05	0.000355	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CDKN1A—esophageal cancer	3.95e-05	0.000355	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GNG7—esophageal cancer	3.93e-05	0.000353	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.89e-05	0.00035	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP26A1—esophageal cancer	3.86e-05	0.000347	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CREBBP—esophageal cancer	3.83e-05	0.000344	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.81e-05	0.000342	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CREBBP—esophageal cancer	3.8e-05	0.000341	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ALOX15—esophageal cancer	3.76e-05	0.000338	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—EGFR—esophageal cancer	3.76e-05	0.000338	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EP300—esophageal cancer	3.76e-05	0.000338	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—EGFR—esophageal cancer	3.73e-05	0.000335	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ALDH2—esophageal cancer	3.69e-05	0.000331	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	3.59e-05	0.000323	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TPI1—esophageal cancer	3.59e-05	0.000322	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTO1—esophageal cancer	3.59e-05	0.000322	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—PIK3CA—esophageal cancer	3.57e-05	0.00032	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTT1—esophageal cancer	3.51e-05	0.000315	CbGpPWpGaD
Desmopressin—PTGS2—Disease—XIAP—esophageal cancer	3.49e-05	0.000314	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP2A6—esophageal cancer	3.47e-05	0.000311	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.45e-05	0.00031	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ALDOB—esophageal cancer	3.44e-05	0.000309	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NOS3—esophageal cancer	3.42e-05	0.000308	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NOS3—esophageal cancer	3.4e-05	0.000305	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GAPDH—esophageal cancer	3.31e-05	0.000297	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.31e-05	0.000297	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ENO1—esophageal cancer	3.29e-05	0.000295	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CRABP1—esophageal cancer	3.28e-05	0.000295	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MYC—esophageal cancer	3.28e-05	0.000294	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PIK3CA—esophageal cancer	3.26e-05	0.000293	CbGpPWpGaD
Desmopressin—PTGS2—Disease—B2M—esophageal cancer	3.25e-05	0.000292	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PIK3CA—esophageal cancer	3.24e-05	0.000291	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PSME2—esophageal cancer	3.24e-05	0.000291	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PSME1—esophageal cancer	3.24e-05	0.000291	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ERBB2—esophageal cancer	3.2e-05	0.000288	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EGFR—esophageal cancer	3.2e-05	0.000288	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.2e-05	0.000287	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ERBB2—esophageal cancer	3.18e-05	0.000286	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GNG7—esophageal cancer	3.12e-05	0.00028	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ENO1—esophageal cancer	3.11e-05	0.00028	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PSME1—esophageal cancer	3.07e-05	0.000276	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PSME2—esophageal cancer	3.07e-05	0.000276	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CALR—esophageal cancer	2.94e-05	0.000264	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ALDH2—esophageal cancer	2.93e-05	0.000263	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FBXW7—esophageal cancer	2.85e-05	0.000256	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CCND1—esophageal cancer	2.83e-05	0.000254	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.83e-05	0.000254	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCND1—esophageal cancer	2.81e-05	0.000252	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.79e-05	0.000251	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTT1—esophageal cancer	2.78e-05	0.00025	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PIK3CA—esophageal cancer	2.78e-05	0.00025	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP2A6—esophageal cancer	2.75e-05	0.000247	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.74e-05	0.000246	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1A—esophageal cancer	2.74e-05	0.000246	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1A—esophageal cancer	2.72e-05	0.000244	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—esophageal cancer	2.69e-05	0.000242	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.63e-05	0.000236	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ENO1—esophageal cancer	2.61e-05	0.000234	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTGS1—esophageal cancer	2.61e-05	0.000234	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EP300—esophageal cancer	2.61e-05	0.000234	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EP300—esophageal cancer	2.59e-05	0.000232	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PSME1—esophageal cancer	2.57e-05	0.000231	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PSME2—esophageal cancer	2.57e-05	0.000231	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—HMOX1—esophageal cancer	2.4e-05	0.000215	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.35e-05	0.000211	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFBR2—esophageal cancer	2.3e-05	0.000207	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ABCB1—esophageal cancer	2.3e-05	0.000207	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MYC—esophageal cancer	2.27e-05	0.000204	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MYC—esophageal cancer	2.25e-05	0.000202	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EGFR—esophageal cancer	2.22e-05	0.000199	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP1B1—esophageal cancer	2.22e-05	0.000199	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EGFR—esophageal cancer	2.2e-05	0.000198	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SMAD4—esophageal cancer	2.18e-05	0.000196	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP19A1—esophageal cancer	2.08e-05	0.000187	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CA—esophageal cancer	1.93e-05	0.000173	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CA—esophageal cancer	1.91e-05	0.000172	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HMOX1—esophageal cancer	1.9e-05	0.000171	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.87e-05	0.000168	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—esophageal cancer	1.86e-05	0.000167	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—esophageal cancer	1.85e-05	0.000166	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ABCB1—esophageal cancer	1.83e-05	0.000164	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HIF1A—esophageal cancer	1.78e-05	0.00016	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.74e-05	0.000156	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOS2—esophageal cancer	1.62e-05	0.000146	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOTCH1—esophageal cancer	1.61e-05	0.000144	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CREBBP—esophageal cancer	1.54e-05	0.000138	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CREBBP—esophageal cancer	1.46e-05	0.000131	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.38e-05	0.000124	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NOS3—esophageal cancer	1.38e-05	0.000124	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOS3—esophageal cancer	1.3e-05	0.000117	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTGS2—esophageal cancer	1.26e-05	0.000113	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CREBBP—esophageal cancer	1.22e-05	0.00011	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB2—esophageal cancer	1.22e-05	0.00011	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NOS3—esophageal cancer	1.09e-05	9.81e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—EP300—esophageal cancer	1.05e-05	9.4e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1A—esophageal cancer	1.04e-05	9.37e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EP300—esophageal cancer	9.93e-06	8.91e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MYC—esophageal cancer	8.65e-06	7.77e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EGFR—esophageal cancer	8.46e-06	7.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—EP300—esophageal cancer	8.31e-06	7.46e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CA—esophageal cancer	7.75e-06	6.96e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CA—esophageal cancer	7.34e-06	6.59e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CA—esophageal cancer	6.15e-06	5.52e-05	CbGpPWpGaD
